Pharmafile Logo

Communiqué Awards 2016: Excellence in Communication of Survey or Market Research Data

July 13, 2016 | Communiqué Awards, Lucid 

The winning programme – Treating beyond symptoms in IBD: The Steroid Assessment Tool.

Our approach to medical education is really helping to improve patient outcomes and change lives.

Inflammatory bowel disease (IBD) affects more than 250,000 patients in the UK. Treatment strategies have progressed to treating beyond the symptoms of IBD, aiming to reduce mucosal inflammation, sustain remission and prevent bowel damage. 

Steroids have a place in the treatment pathway but do not sustain remission and are associated with significant side effects.The European Crohn’s and Colitis Organisation (ECCO) defines appropriate steroid use and recommends an exit strategy for steroid-dependent patients. However, gastroenterologists are not aware that inappropriate steroid use occurs in their own clinical practice.

Using a simple digital tool, UK experts audited their own practice and were surprised to see high steroid use among their patients. The expert group became advocates for change, motivated to share their data, targeting more than 300 UK HCPs with high steroid use, which comprises approximately 22% of UK IBD clinicians. Awareness of inappropriate steroid use, and the changes driven by the self-realisation of the need to optimise steroids, have the potential to impact the care delivered to over 50,000 UK IBD patients.


This content was provided by Lucid Group Communications Limited

Company Details

 Latest Content from  Lucid Group Communications Limited 

Lucid Group sets the vision for its team of committed Mental Health First Aiders

As we approach World Mental Health Day, Lucid's team of Mental Health First Aiders reflect on their training and set the vision for how they will be supporting the organisation...

The Lucid Group Wellbeing Champions embark on their MHFA training

A mentally sound organisation is good for talent and business. Statistics from Mental Health First Aid (MHFA) England point out to mental health illness (such as depression or anxiety) accounting...

Lucid Group Nurtures Talent. Always.

Lockdown and Covid-19 have not stopped us from nurturing and developing the amazing talent we have at Lucid. Growth is at the heart of #LucidLife.So if you're looking for a place...

Lucid Group reaches the finals of the PM360 2020 Trailblazer Initiative Awards

Lucid Group has been named as a finalist in the PM360 2020 Trailblazer Initiative Awards in the HCP Education category, for the program LiBRA 2019: Looking beyond the joint in...

It’s been ten magical years at Lucid Group for Emma Cox

August marks a special work anniversary for Emma Cox who is celebrating 10 years at Lucid Group!Over the past decade, Emma has demonstrated resilience, tenacity and grit with a disarming...

Lucid Group: Digital Delivery in Lockdown

Standing still is the fastest way of moving backwards in today's world. That's why we've been moving forward and transforming at every step to make sure we can continue to...

Lucid Group scoop a win and a high commendation at Communiqué 2020

Due to the COVID-19 pandemic, this year’s Communiqué awards was a virtual ceremony, celebrating some of the most inspiring work and people in medical communications.Lucid Group were delighted to come...

PHARMA POST COVID-19: REVOLUTION OR EVOLUTION?

Post-COVID-19 thinking: outputs from a thought leader forumOn 14 May 2020, a group of industry experts across pharma and biotech Zoomed together to share reflections on the impact of COVID-19...

Lucid Group are shortlisted in three categories for Communiqué 2020

Lucid’s talent for creating industry-leading programmes is clear to see as they celebrate three of its campaigns being shortlisted for Communiqué 2020, as well as making the finals forThe Real...

Taking the ‘free’ out of ‘freelance’ and bringing it in-house

In this month’s Smart Thinking blog on PMLive.com, Stephanie Wasek, now a permanent principal medical writer at Lucid Group, draws her experience to discuss the highs and lows of being...